NCT06493240 2025-11-25
NLCCRIT-LARC
Peking University People's Hospital
Phase 2 Completed
Clinical Trials
11 trialsNCT04518280 2025-01-17
TORCH
Fudan University
Phase 2 Completed
NCT05086627 2024-08-22
Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer
Hebei Medical University Fourth Hospital
Phase 2 Completed
NCT06293612 2024-03-05
MIS-MRC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Completed
NCT05893667 2023-06-12
Evaluation of Inflammatory Markers in LARC Patients
Hospital Pedro Hispano
Completed
NCT04324567 2023-04-03
APR-IMM
Oslo University Hospital
Completed
NCT03770689 2023-03-21
Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer
EMD Serono
Phase 1/2 Completed
NCT03238885 2019-02-04
Predicting Pathological Complete Response of Rectal Cancer With Magnetic Resonance(MR) Radiomics
Peking University Cancer Hospital & Institute
Completed
NCT01589419 2017-11-20
A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer
AbbVie
Phase 1 Completed
NCT00931203 2016-05-04
Trial of Celecoxib With Preoperative Chemo- Radiation for Locally Advanced Rectal Cancer
National Health Research Institutes, Taiwan
Phase 2 Completed
NCT01859442 2014-05-06
The Effect of Cancer Therapies and Exercise on Mitochondrial Energetics and Fitness
Liverpool University Hospitals NHS Foundation Trust
Phase EARLY_PHASE1 Completed